Trileptal (oxcarbazepine)


Oxcarbazepine (or TRILEPTAL®) is mainly prescribed to treat epilepsy and bipolar disorder.

Status: ACTIVE

Class: Mood Stabilizer, Anticonvulsant

FDA Approval: 1999

Dosage Forms: 150 mg, 300 mg, 600 mg

Biological Half-life: 1-5 hours

Side Effects: Dizziness, blurred vision, loss of balance, loss of concentration, slurred speech, headache, nausea, upset stomach, diarrhea, tremors, skin rash

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.fda.gov